Global Footprint SYNLAB operates in more than 20 countries across four continents with a large workforce and over 2,000 medical experts, enabling cross-border collaboration and multi-country contracting opportunities for centralized diagnostic services.

Vet Focus Shift Recent divestments from the veterinary diagnostics segment (assets sold in 2023 to Mars and subsequent regional moves) indicate a sharpened emphasis on core human medical diagnostics, suggesting opportunities to win share in hospitals, clinics, and government labs.

Public Sector Momentum A marquee public sector win in Region Stockholm demonstrates appetite for large-scale, compliance-driven diagnostic services, signaling potential to pursue similar government and regional bids in other markets.

Tech Readiness A mature digital backbone including Google Cloud Platform, IQVIA, UNIX and security-oriented capabilities supports selling points around cloud-based lab information management, data analytics, cybersecurity and scalable digital health solutions.

Enterprise Capacity With tens of thousands of employees worldwide and a broad clinical testing portfolio, SYNLAB offers scale for long-term, high-value contracts and bundled service packages across hospitals, clinics, governments and corporates.